Advertisement
News
Subscribe to MDT Magazine News

Earnings Preview: UnitedHealth reports 1Q earnings

April 19, 2011 9:45 am | by The Associated Press | Comments

Managed care company UnitedHealth Group Inc. becomes the first major health insurer to report first-quarter earnings when it releases results Thursday before the market opens.WHAT TO WATCH FOR: Health insurers finished strong in 2010, as a slowdown in care use helped companies beat analyst...

Pratt & Whitney and Micro Engineering Solutions Experts Announced as EASTEC 2011 Keynotes

April 19, 2011 8:41 am | by Society of Manufacturing Engineers | Comments

WEST SPRINGFIELD, MA (April 19, 2011) — EASTEC 2011, the largest annual manufacturing event on the East Coast, has announced its keynote speakers for the May 17–19 event held at the Eastern States Exposition in West Springfield, MA. More

AstraZeneca Sued Over Alleged Nexium Injuries, According to The Gibson Law Firm

April 19, 2011 8:39 am | by Bio-Medicine.Org | Comments

HOUSTON, April 19, 2011 /- An Ohio woman suffered bone deterioration and broken bones because of hidden risks with pharmaceutical giant AstraZeneca's acid reflux drug Nexium,  The Gibson Law Firm alleges in a lawsuit filed today in Texas federal court. Filed in...

TOPICS:
Advertisement

New Class of Instruments for Flexible Surgery from Apollo Endosurgery® Used in Cancer Therapy

April 19, 2011 8:39 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, April 19, 2011 /- Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the...

TOPICS:

Masimo to Report First Quarter 2011 Financial Results After Market Close on May 3, 2011

April 19, 2011 8:39 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., April 19, 2011 /- Masimo (NASDAQ: MASI ) announced today that it will release first quarter financial results for the period ended April 2, 2011, after the market closes on May 3, 2011. A conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and...

TOPICS:

Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis

April 19, 2011 8:37 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 19, 2011 /- Amira Pharmaceuticals, Inc. announced today that AM152, the company's lead LPA1 antagonist, has been granted an orphan drug designation by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis. Commonly referred to as IPF,...

TOPICS:

Steris System 1 Processor: 6 Month Extension for Healthcare Facilities To Transition to Legally-Marketed Alternatives

April 19, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

FDA has extended the transition period to February 2, 2012. All healthcare facilities must be transitioned from Steris Corporation?s modified System 1 processor (SS1) to legally-marketed alternative devices by that time.

TOPICS:

LabCorp starts tender offer for Orchid Cellmark

April 19, 2011 7:45 am | by The Associated Press | Comments

Laboratory Corp. initiated a tender offer to buy all shares of Orchid Cellmark Inc., a DNA and paternity testing services company, for $85.4 million, or $2.80 per share Tuesday.LabCorp, a clinical lab services company based in Burlington, N.C., said the tender offer, announced earlier this...

Advertisement

Biosign Technologies dismisses CEO, begins search for replacement

April 19, 2011 6:45 am | by The Associated Press | Comments

Biosign Technologies Inc. (TSXV: BIO) says it has dismissed Peter Tassiopoulos as chief executive officer of the company. Its president Radu Leca will take over on an interim basis while the board of directors searches for a new CEO.

Department of Defense Awards LifePort Five-Year Contract for Up to $45.5 million

April 19, 2011 6:37 am | by Bio-Medicine.Org | Comments

WOODLAND, Wash., April 19, 2011 /- LifePort, Inc. announced today that it had been awarded an IDIQ contract by the Defense Logistics Agency permitting orders up to $45.5 million to provide Stanchion Litter Systems (SLS) through the Electronic Catalog (ECAT).  ECAT is an online...

TOPICS:

Sysmex America Signs Distributorship Agreement With LABSCO

April 19, 2011 6:33 am | by Bio-Medicine.Org | Comments

MUNDELEIN, Ill., April 19, 2011 /- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, announced today an amended distributorship agreement with Laboratory Supply Company (LABSCO).  This agreement, which automatically renews for up to...

TOPICS:

Omeros Announces Publication of MASP-2 Data in Proceedings of the National Academy of Sciences

April 19, 2011 5:35 am | by Bio-Medicine.Org | Comments

SEATTLE, April 19, 2011 /- Omeros Corporation (NASDAQ: OMER ) today announced that research on mannan-binding lectin-associated serine protease-2 (MASP-2) has been published in the April 18, 2011 Early Online Edition of the Proceedings of the National Academy of Sciences (PNAS)....

TOPICS:

Abaxis to Report Fourth Quarter and Fiscal Year 2011 Financial Results Thursday, April 28, 2011

April 19, 2011 5:35 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., April 19, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011. The call...

TOPICS:

Southern Home Medical Equipment Launches Respi-Care Respiratory Therapy Program

April 19, 2011 5:34 am | by Bio-Medicine.Org | Comments

LYMAN, S.C., April 19, 2011 /- Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, announced today that in response to the growing demand for specialized solutions for...

TOPICS:

MedicaMetrix Signs Letter of Intent to Use Vytex® Natural Rubber Latex as Material of Choice in ProstaGlove™

April 19, 2011 5:32 am | by Bio-Medicine.Org | Comments

ATLANTA, April 19, 2011 /- Vystar® Corporation (OTCBB: VYST), the creator of Vytex® Natural Rubber Latex (NRL), a multi-patented, all-natural raw material that contains significantly reduced levels of the antigenic proteins found in natural rubber latex, announces that...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading